Preoperative GLP-1 use tied to less atrial fibrillation after CABG
Researchers reported no apparent rise in mortality or major adverse cardiovascular and cerebral events among patients on GLP-1 receptor agonists before surgery.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 15 00:30 ETSource: Medical Dialogues
The wire
- 01A US study found preoperative GLP-1 receptor agonist use was associated with lower incidence of new-onset atrial fibrillation after coronary artery bypass grafting.
- 02Perioperative teams weighing whether to hold GLP-1s before cardiac surgery now have data pointing to a possible benefit rather than harm.
- 03The authors stress the finding is associational and call for further investigation; no effect on mortality or MACCE was observed.
From the source
Read at medicaldialogues.inPreoperative GLP-1 Use Linked to Lower Atrial Fibrillation Risk After CABG: Study
USA: Preoperative use of glucagon-like peptide-1 (GLP-1) receptor agonists was associated with a lower incidence of new-onset atrial fibrillation following coronary artery bypass grafting (CABG) , without an apparent increase in mortality or major adverse cardiovascular and cerebral events (MACCE), a new study has revealed. The findings suggest that GLP-1 therapy may offer perioperative benefits f